Clinical Trials Browser

Gastroenteropancreatic Neuroendocrine Tumors × Clear all

NCT07165886 2025-09-10

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Phase 2/3 Recruiting

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02608203 2022-10-14

GEP-NOC

Phase 2/3 Completed

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02630654 2021-12-07

EXPLAIN

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02730104 2020-06-26

Community-based Neuroendocrine Tumor (NET) Research Study

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02162446 2019-10-02

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Phase 1/2 Completed

12 enrolled 11 charts

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT02231762 2019-05-06

SONNET

Phase 2 Completed

57 enrolled 20 charts

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors